Table 1.
Relationship between clinical pathological traits and WDR45B expression in HCC patients from Zhongnan Hospital of Wuhan University.
| Variables | Total HCC Patients | WDR45B Expression in HCC Patients | χ2 | p | ||
|---|---|---|---|---|---|---|
| High | Low | |||||
| Age, n (%) | >45 | 42 (75.0%) | 24 (85.7%) | 18 (64.3%) | 3.429 | 0.121 |
| ≤45 | 14 (25.0%) | 4 (14.3%) | 10 (35.7%) | |||
| Sex, n (%) | male | 55 (98.2%) | 27 (96.4%) | 28 (100%) | 1.018 | 1.000 |
| female | 1 (2.8%) | 1 (3.6%) | 0 (0%) | |||
| Grade, n (%) | G1-G2 | 39 (69.6%) | 15 (53.6%) | 24 (85.7%) | 6.842 | 0.019 * |
| G3 | 17 (30.4%) | 13 (46.4%) | 4 (14.3%) | |||
| T stage, n (%) | T1-T2 | 33 (58.9%) | 13 (46.4%) | 20 (71.4%) | 3.615 | 0.102 |
| T3-T4 | 23 (41.1%) | 15 (53.6%) | 8 (28.6%) | |||
| macroscope vein invasion, n (%) | visible | 6 (10.7%) | 4 (14.3%) | 2 (7.1%) | 0.747 | 0.669 |
| invisible | 50 (89.3%) | 24 (85.7%) | 26 (92.9%) | |||
| microvascular invasion, n (%) | visible | 36 (64.3%) | 20 (71.4%) | 16 (57.1%) | 1.244 | 0.403 |
| invisible | 20 (35.7%) | 8 (28.6%) | 12 (42.9%) | |||
| cirrhosis, n (%) | yes | 22 (39.3%) | 12 (42.9%) | 10 (35.7%) | 0.299 | 0.785 |
| no | 34 (60.7%) | 16 (57.1%) | 18 (64.3%) | |||
| tumor involvement, n (%) | restricted to liver | 47 (88.7%) | 23 (85.2%) | 24 (92.3%) | 0.669 | 0.669 |
| invade portal vein, gallbladder or visceral peritoneum | 6 (11.3%) | 4 (14.8%) | 2 (7.7%) | |||
| AFP (IHC), n (%) | positive (+) | 16 (61.5%) | 9 (75.0%) | 7 (50.0%) | 1.706 | 0.248 |
| negative (−) | 10 (38.5%) | 3 (25.0%) | 7 (50.0%) | |||
* p < 0.05.